Key result
The DSP R451G missense mutation is strongly linked to biventricular arrhythmogenic cardiomyopathy and promotes disease by increasing the vulnerability of desmoplakin to calpain-mediated degradation.
Why the study?
Arrhythmogenic cardiomyopathy is an inherited disorder with variable genetic etiologies, and the precise molecular pathology of a clinical DSP variant needed to be understood.
Answers are grounded in this paper and cite their sources.
Augmented calpain-mediated degradation of desmoplakin represents a shared pathological mechanism for select ACM-linked missense variants, offering a potential new therapeutic target for inherited cardiomyopathies.
Arrhythmogenic cardiomyopathy (ACM) is an inherited disorder with variable genetic etiologies. Here we focused on understanding the precise molecular pathology of a single clinical variant in DSP, the gene encoding desmoplakin. We initially identified a novel missense desmoplakin variant (p.R451G) in a patient diagnosed with biventricular ACM. An extensive single-family ACM cohort was assembled, revealing a pattern of coinheritance for R451G desmoplakin and the ACM phenotype. An in vitro model system using patient-derived induced pluripotent stem cell lines showed depressed levels of desmoplakin in the absence of abnormal electrical propagation. Molecular dynamics simulations of desmoplakin R451G revealed no overt structural changes, but a significant loss of intramolecular interactions surrounding a putative calpain target site was observed. Protein degradation assays of recombinant desmoplakin R451G confirmed increased calpain vulnerability. In silico screening identified a subset of 3 additional ACM-linked desmoplakin missense mutations with apparent enhanced calpain susceptibility, predictions that were confirmed experimentally. Like R451G, these mutations are found in families with biventricular ACM. We conclude that augmented calpain-mediated degradation of desmoplakin represents a shared pathological mechanism for select ACM-linked missense variants. This approach for identifying variants with shared molecular pathologies may represent a powerful new strategy for understanding and treating inherited cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Ng et al. (2019) studied Arrhythmogenic cardiomyopathy (ACM) (n=116). DSP R451G mutation vs. Wild-type DSP (mutation-negative family members) was evaluated on Coinheritance of the ACM phenotype and the p.R451G mutation (genetic linkage) (LOD score 7.65). The DSP R451G missense mutation is strongly linked to biventricular arrhythmogenic cardiomyopathy and promotes disease by increasing the vulnerability of desmoplakin to calpain-mediated degradation.
Synapse has enriched 10 related papers. Consider them for comparative context: